The proportion of Korean CEO in multinational pharmaceutical companies has increased by more than twice for about five years

Published: 2014-07-30 10:53:14

Updated: 2014-07-30 10:53:14

It was identified that the proportion of Korean CEO in multinational pharmaceutical companies has increased by more than twice for about five years.

According to the CEO status of multinational pharmaceutical companies in Korea compiled by Dailypharm, the proportion of Korean CEO increased from 33% in 2009 to 69% in 2014.

Five pharmaceutical companies including Takeda, Leo Pharma, Menarini, C...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.